| AURO-LOSARTAN (25.0 MG) | 02403323 | Marketed | Auro Pharma Inc. | Mar 2013 |
| AURO-LOSARTAN (50.0 MG) | 02403331 | Marketed | Auro Pharma Inc. | Mar 2013 |
| AURO-LOSARTAN (100.0 MG) | 02403358 | Marketed | Auro Pharma Inc. | Mar 2013 |
| AURO-LOSARTAN HCT (50 MG) | 02423642 | Marketed | Auro Pharma Inc. | Apr 2014 |
| AURO-LOSARTAN HCT (100 MG) | 02423650 | Marketed | Auro Pharma Inc. | Apr 2014 |
| AURO-LOSARTAN HCT (100 MG) | 02423669 | Marketed | Auro Pharma Inc. | Apr 2014 |
| COZAAR (25 MG) | 02182815 | Marketed | Organon Canada Inc. | Feb 2022 |
| COZAAR (50 MG) | 02182874 | Marketed | Organon Canada Inc. | Jan 2022 |
| COZAAR (100 MG) | 02182882 | Marketed | Organon Canada Inc. | Jan 2022 |
| HYZAAR (50 MG) | 02230047 | Marketed | Organon Canada Inc. | Mar 2022 |
| HYZAAR (100 MG) | 02297841 | Marketed | Organon Canada Inc. | Apr 2022 |
| HYZAAR DS (100 MG) | 02241007 | Marketed | Organon Canada Inc. | Apr 2022 |
| JAMP-LOSARTAN (25 MG) | 02398834 | Marketed | JAMP Pharma Corporation | Jun 2016 |
| JAMP-LOSARTAN (50 MG) | 02398842 | Marketed | JAMP Pharma Corporation | Jun 2016 |
| JAMP-LOSARTAN (100 MG) | 02398850 | Marketed | JAMP Pharma Corporation | Jun 2016 |
| LOSARTAN (25 MG) | 02388790 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2025 |
| LOSARTAN (50 MG) | 02388804 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2025 |
| LOSARTAN (100 MG) | 02388812 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2025 |
| LOSARTAN (25 MG) | 02388863 | Marketed | Sanis Health Inc. | Jul 2012 |
| LOSARTAN (50 MG) | 02388871 | Marketed | Sanis Health Inc. | Jul 2012 |
| LOSARTAN (100 MG) | 02388898 | Marketed | Sanis Health Inc. | Jul 2012 |
| LOSARTAN HCT (50 MG) | 02388960 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2025 |
| LOSARTAN HCT (100 MG) | 02388979 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2025 |
| LOSARTAN HCT DS (100 MG) | 02388987 | Marketed | Sivem Pharmaceuticals Ulc | Oct 2025 |
| LOSARTAN/HCTZ (50 MG) | 02427648 | Marketed | Sanis Health Inc. | Jul 2014 |
| LOSARTAN/HCTZ (100 MG) | 02427656 | Marketed | Sanis Health Inc. | Aug 2020 |
| LOSARTAN/HCTZ (100 MG) | 02427664 | Marketed | Sanis Health Inc. | Jul 2014 |
| MINT-LOSARTAN (25 MG) | 02405733 | Marketed | Mint Pharmaceuticals Inc | Mar 2024 |
| MINT-LOSARTAN (50 MG) | 02405741 | Marketed | Mint Pharmaceuticals Inc | Mar 2024 |
| MINT-LOSARTAN (100 MG) | 02405768 | Marketed | Mint Pharmaceuticals Inc | Mar 2024 |
| MINT-LOSARTAN/HCTZ (50 MG) | 02389657 | Marketed | Mint Pharmaceuticals Inc | Jun 2024 |
| MINT-LOSARTAN/HCTZ (100 MG) | 02389665 | Marketed | Mint Pharmaceuticals Inc | Jun 2024 |
| MINT-LOSARTAN/HCTZ DS (100.0 MG) | 02389673 | Marketed | Mint Pharmaceuticals Inc | Jun 2024 |
| PMS-LOSARTAN (25 MG) | 02309750 | Marketed | Pharmascience Inc. | Dec 2020 |
| PMS-LOSARTAN (50 MG) | 02309769 | Marketed | Pharmascience Inc. | Nov 2020 |
| PMS-LOSARTAN (100 MG) | 02309777 | Marketed | Pharmascience Inc. | Jan 2012 |
| PMS-LOSARTAN-HCTZ (50 MG) | 02392224 | Marketed | Pharmascience Inc. | Sep 2012 |
| PMS-LOSARTAN-HCTZ (100 MG) | 02392232 | Marketed | Pharmascience Inc. | Sep 2012 |
| PMS-LOSARTAN-HCTZ (100 MG) | 02392240 | Marketed | Pharmascience Inc. | Sep 2012 |
| SANDOZ LOSARTAN (25 MG) | 02313332 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ LOSARTAN (50 MG) | 02313340 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ LOSARTAN (100 MG) | 02313359 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ LOSARTAN HCT (50 MG) | 02313375 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ LOSARTAN HCT (100 MG) | 02362449 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| SANDOZ LOSARTAN HCT DS (100 MG) | 02313383 | Marketed | Sandoz Canada Inc. | Jan 2012 |
| TEVA-LOSARTAN (50 MG) | 02357968 | Marketed | Teva Canada Limited | Jan 2012 |
| TEVA-LOSARTAN (100 MG) | 02357976 | Marketed | Teva Canada Limited | Jan 2012 |
| TEVA-LOSARTAN (25 MG) | 02380838 | Marketed | Teva Canada Limited | Feb 2012 |
| AG-LOSARTAN (25 MG) | 02441195 | Dormant | Angita Pharma Inc. | Jul 2020 |
| AG-LOSARTAN (50 MG) | 02441209 | Dormant | Angita Pharma Inc. | Jul 2020 |
| AG-LOSARTAN (100 MG) | 02441217 | Dormant | Angita Pharma Inc. | Jul 2020 |
| APO-LOSARTAN (50 MG) | 02353504 | Dormant | Apotex Inc. | Apr 2019 |
| APO-LOSARTAN (100 MG) | 02353512 | Dormant | Apotex Inc. | Dec 2019 |
| LOSARTAN POTASSIUM (25 MG) | 02395193 | Approved | Jubilant Generics Limited | Oct 2012 |
| LOSARTAN POTASSIUM (50 MG) | 02395207 | Approved | Jubilant Generics Limited | Oct 2012 |
| LOSARTAN POTASSIUM (100 MG) | 02395215 | Approved | Jubilant Generics Limited | Oct 2012 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (50 MG) | 02396572 | Approved | Jubilant Generics Limited | May 2013 |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (100 MG) | 02396580 | Approved | Jubilant Generics Limited | May 2013 |
| SEPTA-LOSARTAN (25 MG) | 02424967 | Dormant | Septa Pharmaceuticals Inc | Jul 2020 |
| SEPTA-LOSARTAN (50 MG) | 02424975 | Dormant | Septa Pharmaceuticals Inc | Jul 2020 |
| SEPTA-LOSARTAN (100 MG) | 02424983 | Dormant | Septa Pharmaceuticals Inc | Jul 2020 |
| SEPTA-LOSARTAN HCTZ (50 MG) | 02428539 | Dormant | Septa Pharmaceuticals Inc | Jul 2017 |
| SEPTA-LOSARTAN HCTZ (100 MG) | 02428547 | Dormant | Septa Pharmaceuticals Inc | Jul 2017 |
| TARO-LOSARTAN (25 MG) | 02404451 | Dormant | Sun Pharma Canada Inc. | Mar 2023 |
| TARO-LOSARTAN (50 MG) | 02404478 | Dormant | Sun Pharma Canada Inc. | Mar 2023 |
| TARO-LOSARTAN (100 MG) | 02404486 | Dormant | Sun Pharma Canada Inc. | Mar 2023 |
| ACT LOSARTAN (25 MG) | 02354829 | Cancelled Post Market | Actavis Pharma Company | Aug 2019 |
| ACT LOSARTAN (50 MG) | 02354837 | Cancelled Post Market | Actavis Pharma Company | Aug 2019 |
| ACT LOSARTAN (100 MG) | 02354845 | Cancelled Post Market | Actavis Pharma Company | Aug 2019 |
| ACT LOSARTAN/HCT (50 MG) | 02388251 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT LOSARTAN/HCT (100 MG) | 02388278 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT LOSARTAN/HCT (100 MG) | 02388286 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| AG-LOSARTAN HCTZ (50 MG) | 02474654 | Cancelled Pre Market | Angita Pharma Inc. | Sep 2022 |
| AG-LOSARTAN HCTZ (100 MG) | 02474662 | Cancelled Pre Market | Angita Pharma Inc. | Sep 2022 |
| APO-LOSARTAN (25 MG) | 02379058 | Cancelled Post Market | Apotex Inc. | Apr 2025 |
| APO-LOSARTAN/HCTZ (50 MG) | 02371235 | Cancelled Post Market | Apotex Inc. | Apr 2025 |
| APO-LOSARTAN/HCTZ (100 MG) | 02371243 | Cancelled Post Market | Apotex Inc. | Apr 2025 |
| APO-LOSARTAN/HCTZ (100 MG) | 02371251 | Cancelled Post Market | Apotex Inc. | Apr 2025 |
| BIO-LOSARTAN (25 MG) | 02445964 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| BIO-LOSARTAN (50 MG) | 02445972 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| BIO-LOSARTAN (100 MG) | 02445980 | Cancelled Post Market | Biomed Pharma | Jul 2022 |
| DOM-LOSARTAN (25 MG) | 02314479 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-LOSARTAN (50 MG) | 02314487 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| DOM-LOSARTAN (100 MG) | 02314495 | Cancelled Pre Market | Dominion Pharmacal | May 2025 |
| IPG-LOSARTAN (25 MG) | 02420996 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | May 2021 |
| IPG-LOSARTAN (50 MG) | 02421003 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | May 2021 |
| IPG-LOSARTAN (100 MG) | 02421011 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | May 2021 |
| JAMP-LOSARTAN HCTZ (50 MG) | 02408244 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| JAMP-LOSARTAN HCTZ (100 MG) | 02408252 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| LOSARTAN (25 MG) | 02394367 | Cancelled Post Market | Pro Doc Limitee | Jul 2023 |
| LOSARTAN (50 MG) | 02394375 | Cancelled Post Market | Pro Doc Limitee | Jul 2023 |
| LOSARTAN (100 MG) | 02394383 | Cancelled Post Market | Pro Doc Limitee | Jul 2023 |
| LOSARTAN (25 MG) | 02399296 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| LOSARTAN (50 MG) | 02399318 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| LOSARTAN (100 MG) | 02399326 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| LOSARTAN (25 MG) | 02410435 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| LOSARTAN (50 MG) | 02410443 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| LOSARTAN (100 MG) | 02410451 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| LOSARTAN (25 MG) | 02433346 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| LOSARTAN (50 MG) | 02433354 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| LOSARTAN (100 MG) | 02433362 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| LOSARTAN-HCTZ (50 MG) | 02394391 | Cancelled Post Market | Pro Doc Limitee | Jul 2023 |
| LOSARTAN-HCTZ (100 MG) | 02394405 | Cancelled Post Market | Pro Doc Limitee | Jul 2023 |
| LOSARTAN-HCTZ (100 MG) | 02394413 | Cancelled Post Market | Pro Doc Limitee | Jul 2023 |
| LOSARTAN/HCT (50 MG) | 02433370 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| LOSARTAN/HCT (100 MG) | 02433389 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| LOSARTAN/HCT (100 MG) | 02433397 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| LOSARTAN/HCTZ (50 MG) | 02398524 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| LOSARTAN/HCTZ (100 MG) | 02398532 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| LOSARTAN/HCTZ (100 MG) | 02398540 | Cancelled Pre Market | Frosst A Division Of Merck Canada Inc | May 2016 |
| MAR-LOSARTAN (25 MG) | 02422468 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | May 2021 |
| MAR-LOSARTAN (50 MG) | 02422476 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | May 2021 |
| MAR-LOSARTAN (100 MG) | 02422484 | Cancelled Pre Market | Marcan Pharmaceuticals Inc. | May 2021 |
| MYLAN-LOSARTAN (25 MG) | 02368277 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Aug 2018 |
| MYLAN-LOSARTAN (50 MG) | 02368285 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Aug 2018 |
| MYLAN-LOSARTAN (100 MG) | 02368293 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Aug 2018 |
| MYLAN-LOSARTAN HCTZ (50 MG) | 02378078 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | May 2018 |
| MYLAN-LOSARTAN HCTZ (100 MG) | 02378086 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | May 2018 |
| MYLAN-LOSARTAN HCTZ (100 MG) | 02378094 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | May 2018 |
| PHL-LOSARTAN (25 MG) | 02314444 | Cancelled Pre Market | Pharmel Inc. | May 2017 |
| PHL-LOSARTAN (50 MG) | 02314452 | Cancelled Pre Market | Pharmel Inc. | May 2017 |
| PHL-LOSARTAN (100 MG) | 02314460 | Cancelled Pre Market | Pharmel Inc. | May 2017 |
| PRIVA-LOSARTAN (25 MG) | 02446693 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-LOSARTAN (50 MG) | 02446707 | Cancelled Post Market | Pharmapar Inc. | Jul 2021 |
| PRIVA-LOSARTAN (100 MG) | 02446715 | Cancelled Post Market | Pharmapar Inc. | Jul 2022 |
| RATIO-LOSARTAN HCTZ (100.0 MG) | 02358271 | Cancelled Pre Market | Teva Canada Limited | Oct 2015 |
| TEVA-LOSARTAN/HCTZ (50.0 MG) | 02358263 | Cancelled Post Market | Teva Canada Limited | Jul 2026 |
| TEVA-LOSARTAN/HCTZ (100 MG) | 02377144 | Cancelled Post Market | Teva Canada Limited | Oct 2020 |
| TEVA-LOSARTAN/HCTZ (100 MG) | 02377152 | Cancelled Post Market | Teva Canada Limited | Dec 2020 |
| VAN-LOSARTAN (25 MG) | 02426595 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-LOSARTAN (50 MG) | 02426609 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-LOSARTAN (100 MG) | 02426617 | Cancelled Post Market | Vanc Pharmaceuticals Inc | Aug 2019 |
| VAN-LOSARTAN-HCTZ (50 MG) | 02427036 | Cancelled Pre Market | Vanc Pharmaceuticals Inc | Jul 2019 |
| VAN-LOSARTAN-HCTZ (100 MG) | 02427044 | Cancelled Pre Market | Vanc Pharmaceuticals Inc | Jul 2019 |